Wednesday, May 11, 2011

University Of Minnesota guilty of allowing academic bullying: Charles Schulz, AstraZeneca & Dan Markingson CAFE trial saga

The story about Carl Elliott, who wrote an investigative article on the Dan Markingson suicide Seroquel trial is in the news again via

William Heisel's Antidote: Investigating Untold Health Stories

"A war of words has erupted at the University of Minnesota campus over bioethics writer and UM professor Carl Elliott’s reporting into the suicide of a schizophrenic patient enrolled in a clinical trial.

It has pitted the university’s general counsel against Elliott and a group of outspoken faculty members who have been pushing for a larger investigation into the death of Dan Markingson."


AND

"Because Elliott has repeatedly named the doctors who treated Markingson, Dr. Charles Schulz and Dr. Stephen C. Olson, his fellow professors at the University of Minnesota, his writings have made for an uncomfortable situation on campus.

In the past few months, discomfort has spilled over into what Elliott and his supporters feel is an actual attempt to shut him up.The university’s general counsel, Mark Rotenberg, in February asked the university’s Academic Freedom and Tenure committee to take up the question of whether a faculty member writing about another faculty member and using factually incorrect statements should be protected by academic freedom."-Heisel



ALSO

in the Minnesota post:

"You wouldn’t know it from reading local media, but in recent weeks the University of Minnesota has become Ground Zero in a high-stakes controversy over academic freedom. A number of faculty members have accused the administration of trying to silence a professor who has repeatedly drawn national attention to research protocols he charges are unethical.
It would appear that the simmering dispute is about to become a full-on conflagration.


Last fall, the magazine Mother Jones published a lengthy investigative article penned by Carl Elliott, a U of M bioethics professor and highly respected author of two books. The most recent, “White Coat, Black Hat: Adventures on the Dark Side of Medicine,” expands on the controversy."

--

In the meantime, Dr.Charles Schulz CONTINUES to trial the antipsychotic Seroquel at the University of Minnesota:

Seroquel Extended Release (XR) for the Management of Borderline Personality Disorder (BPD)

This study is currently recruiting participants.

Verified on September 2010 by University of Minnesota - Clinical and Translational Science Institute


First Received on April 10, 2009. Last Updated on September 8, 2010 History of Changes

Sponsor: University of Minnesota - Clinical and Translational Science Institute
Collaborators: AstraZeneca
University of Iowa
Mclean Hospital

Information provided by: University of Minnesota - Clinical and Translational Science Institute
ClinicalTrials.gov Identifier: NCT00880919

United States, Minnesota
University of Minnesota Medical Center, Fairview Riverside Recruiting
Minneapolis, Minnesota, United States, 55454
Contact: Ann Romine, RN 612-627-4843 romi0004@umn.edu

Principal Investigator: S. Charles Schulz, MD
---

Could this be more than academic freedom at stake? could this be a direct assault from the Big Pharma company sponsoring the Seroquel trial headed by Charles Schulz? could it be AstraZeneca attempting to silence Carl Elliott?

0 comments: